Filtered By:
Specialty: American Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 49 results found since Jan 2013.
Cingulate bolsters cash with $3 million in debt financing from investor
The company is chasing a huge market for ADHD treatment, but also is working hard to fund its effort without revenue.
Source: bizjournals.com Health Care:Physician Practices headlines - May 12, 2023 Category: American Health Authors: Brian Kaberline Source Type: news
What's Behind Shortages of Adderall, Ozempic and Other Meds?
For some drugs, such as stimulants that treat ADHD, several factors fueled a shortage and make it hard to predict when it will end.
Source: Arkansas Business - Health Care - May 8, 2023 Category: American Health Source Type: news
School prevalence of stimulant therapy for ADHD associated with higher rates of prescription stimulant misuse among teens
NIH study signals importance of monitoring and screening for prescription stimulant misuse in schools.
Source: National Institutes of Health (NIH) News Releases - April 18, 2023 Category: American Health Source Type: news
Simulated driving program reduces crash risk for teens with ADHD in small study
NIH-funded program teaches teens to avoid long glances away from roadway.
Source: National Institutes of Health (NIH) News Releases - November 30, 2022 Category: American Health Source Type: news
NIH researchers unlock pattern of gene activity for ADHD
New study uses postmortem brain tissues to understand genomic differences in individuals with attention deficit hyperactivity disorder.
Source: National Institutes of Health (NIH) News Releases - November 16, 2022 Category: American Health Source Type: news
What's With the National Adderall Shortage?
(MedPage Today) -- Patients who rely on medication to treat their attention deficit-hyperactivity disorder (ADHD) are struggling to fill their prescriptions because of a national shortage of amphetamine/dextroamphetamine (Adderall).
On Reddit...
Source: MedPage Today Public Health - October 19, 2022 Category: American Health Source Type: news
FDA Official Pressured Via Text; More ADHD Telemed Scrutiny; PE Eyes Ophthalmology
(MedPage Today) -- Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week.
Former FDA Commissioner Pressured Via Text for Drug Company Favors
Paul Knoepfler, PhD...
Source: MedPage Today Public Health - September 21, 2022 Category: American Health Source Type: news
ADHD drug startup Done Global is under investigation by the Drug Enforcement Agency
Startups thought prescribing ADHD medication online was a huge growth opportunity. Now the federal government is trying to reign it in.
Source: bizjournals.com Health Care:Industry Regulation headlines - September 15, 2022 Category: American Health Authors: William Hicks Source Type: news
Lab Notes: CHOP develops ADHD diagnostic tool, GSK unveils flu vaccine plans, Helius launches training program
This week's Lab Notes has updates from CHOP, Helius Medical, GSK and more.
Source: bizjournals.com Health Care:Physician Practices headlines - July 15, 2022 Category: American Health Authors: John George Source Type: news
USF develops 'brain painting' method for ADHD treatment
The technology can monitor how long a student focuses without a wandering mind all while painting on a virtual canvas.
Source: bizjournals.com Health Care:Physician Practices headlines - June 1, 2022 Category: American Health Authors: Lauren Coffey Source Type: news
Cingulate wants to be the next Eli Lilly — and stay in Kansas City
Cingulate, which went public last year, developed an innovative drug-delivery platform that could be game-changing for patients dealing with conditions such as ADHD and anxiety. CEO Shane Schaffer sees its application extending to other conditions.
Source: bizjournals.com Health Care:Physician Practices headlines - May 19, 2022 Category: American Health Authors: Leslie Collins Source Type: news
S.F.'s online ADHD prescription boom may be coming to an end
Ever a cradle of innovation, San Francisco spawned a number of startups in recent years specializing in writing prescriptions for ADHD and other mental illnesses completely online, but this niche segment appears to be imploding in recent days.
Cerebral, the mental health telemedicine sector's largest player, is stopping prescribing controlled substances like Adderall and Ritalin to treat ADHD, according to a blog post by the company's CEO Kyle Robertson. This came just days after the company's…
Source: bizjournals.com Health Care:Physician Practices headlines - May 4, 2022 Category: American Health Authors: William Hicks Source Type: news
Vallon Pharmaceuticals stock plunges 70% after ADHD drug candidate misses primary endpoint
Vallon Pharmaceuticals' stock plunged by more than 70% Monday after the Philadelphia biopharmaceutical company announced disappointing clinical trial results for its experimental treatment of attention deficit hyperactivity disorder.
The company's new drug candidate, ADAIR — an acronym for Abuse Deterrent Amphetamine Immediate Release — is a proprietary abuse-deterrent formulation of dextroamphetamine for the treatment of ADHD. Dextroamphetamine has been used clinically for more than 50 years.…
Source: bizjournals.com Health Care:Physician Practices headlines - March 21, 2022 Category: American Health Authors: John George Source Type: news
QuickStats: Percentage of Children Aged 3-17 Years Who Ever Received a Diagnosis of Attention-Deficit/Hyperactivity Disorder, by Sex and Age Group - National Health Interview Survey, United States, 2019
This report describes the percentage of children aged 3-17 years in the United States who ever received a diagnosis of Attention-Deficit/Hyperactivity Disorder.
Source: CDC Morbidity and Mortality Weekly Report - July 22, 2021 Category: American Health Tags: ADHD (Attention Deficit/Hyperactivity Disorder) Attention Deficit/Hyperactivity Disorder (ADHD) MMWR Morbidity & Mortality Weekly Report Source Type: news
Do I Have Adult ADHD / ADD? - Take the Quiz
Test your knowledge of attention deficit/hyperactivity disorder ... Other estimates put the number as high as 4 percent. ... What percentage of college students do surveys show are misusing Adderal...
Source: AARP.org News - May 3, 2021 Category: American Health Source Type: news
